Novel therapies target hyperkalemia, improve use of RAAS inhibitors

23.10.20151749
Hyperkalemia occurs frequently in patients with chronic kidney disease and HF, and is also a common complication of renin-angiotensin-aldosterone inhibitor use.

Трансляции заседаний общества ССХ и лекций для ординаторов и аспирантов 1 года на сайте racvs.ru 23 октября

22.10.20151868
На сайте Ассоциации сердечно-сосудистых хирургов России (racvs.ru) продолжаются онлайн трансляции лекций для ординаторов и аспирантов первого года обучения.

Factors associated with 30-day readmission of patients with heart failure from a Japanese administrative database

22.10.20151608
Numerous studies have been conducted in many countries to identify the factors associated with readmission of patients with heart failure (HF).

Beta-blockers may increase perioperative MACE, mortality risk in uncomplicated hypertension

21.10.20151659
Perioperative treatment with a beta-blocker may be linked to elevated risk for major adverse CV events and all-cause mortality in patients with uncomplicated hypertension undergoing noncardiac surgery, according to recent findings.

Young women with acute MI less likely to receive, adhere to pharmacotherapy

20.10.20151577
Young women with acute MI are less likely than young men to use secondary prevention CV medications, according to study findings published in Circulation: Cardiovascular Quality and Outcomes.

Downgrading risk to minimize statin use in an era of increased statin eligibility

19.10.20151842
The 2013 American College of Cardiology/American Heart Association guidelines introduced the 10-year atherosclerotic CVD risk estimator to guide clinician–patient risk discussions about statin therapy.

RIVER-PCI: Ranolazine fails to benefit patients with incomplete revascularization after PCI

15.10.20151648
Treatment with ranolazine did not lower rates of ischemia-driven revascularization or hospitalization without revascularization in patients with a history of chronic angina who had incomplete revascularization after PCI, according to late-breaking clinical trial results presented at the annual TCT Scientific Symposium.
Данный сайт и вся информация на нём предназначена для медицинских работников. Продолжая просмотр, вы соглашаетесь и подтверждаете, что являетесь медицинским работником.